Eventide Asset Management, LLC Aura Biosciences, Inc. Transaction History
Eventide Asset Management, LLC
- $6.2 Billion
- Q1 2024
A detailed history of Eventide Asset Management, LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 5,802,682 shares of AURA stock, worth $42.6 Million. This represents 0.73% of its overall portfolio holdings.
Number of Shares
5,802,682
Previous 5,802,682
-0.0%
Holding current value
$42.6 Million
Previous $51.4 Million
11.4%
% of portfolio
0.73%
Previous 0.86%
Shares
5 transactions
Others Institutions Holding AURA
# of Institutions
79Shares Held
39.9MCall Options Held
400Put Options Held
1.5K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$50.9 Million0.5% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.47MShares$32.8 Million0.07% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.68MShares$27 Million0.01% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$22.3 Million6.26% of portfolio
-
Black Rock Inc. New York, NY2.44MShares$18 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $215M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...